Vascular

C.R. Bard, Becton Dickinson Leading Australia Vascular Access Device Market Fueled by the Introduction of New Products and Technology

The increasing prevalence of diseases and conditions that require long-term vascular access is driving innovation and the increased use of vascular access devices in Australia.

Read More

C.R. Bard, Medikit Lead Japan Vascular Access Market Fueled by Switch from Central Venous to Peripherally Inserted Central Catheters

The increasing prevalence of diseases and conditions that require long-term vascular access is fueling the increased use of vascular access devices and is expected to be a driving factor in the Japanese market

Read More

Becton Dickinson, B. Braun Lead European Syringe and Needle Market due to Conversion from Conventional to Safety Needles

The syringe and needle segment is experiencing different growth trends. The Europe market for syringes and needles is expected to reach over €675 million by 2023 due to a strong shift towards the use of more expensive safety needles.

Read More

Becton Dickinson, B.Braun Lead European Vascular Access Device Market with PIVC Competitive Pricing

The Europe market for vascular access devices and accessories is expected to increase to reach over €1 billion by 2023. Europe-wide legislation promoting the use of safety devices such as syringes and needles in the workplace has resulted in market growth.

Read More

Becton Dickinson, CR Bard Lead US Vascular Access Device Market with Premium Safety Products

The U.S. market for vascular access devices and accessories will grow to reach a market value of just over $5 billion by 2022. Market growth will be driven by government policies that encourage safer practices and products.

Read More

WL GORE TIGRIS Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease

Register to receive a free US Peripheral Vascular Device Market – 2016 report synopsis and brochure W.L. Gore recently announced the U.S. Food and Drug Administration (FDA) approval of the GORE® TIGRIS® Vascular Stent, a dual-component stent with a fluoropolymer

Read More

Bio2 Medical Gains FDA Clearance for the Angel® Catheter, the First Prophylactic Use Indication for Pulmonary Embolisms

This 510(k) clearance includes a first ever, prophylactic indication for a medical device to protect critically ill patients at high-risk for pulmonary embolism (PE) and contraindicated for anticoagulation.

Read More

Medtronic, Cook Medical Lead Europe Peripheral Vascular Market due to Increase Use of Transcatheter Embolization Devices

The European peripheral vascular device market value is expected to reach over €1.4 billion by 2022. The strong growth in this market is a result of the increase in usage of radiolabeled and drug-eluting beads.

Read More

C.R. Bard, AngioDynamics Lead Competitive U.S. Implantable Port Market Driven by Increased Use in Cancer Treatments

The U.S. power-injectable implantable port market is expected to increase over the forecast period, driven predominantly by cancer treatments that require long-term vascular access.

Read More

W.L. Gore, Medtronic Lead US Peripheral Vascular Covered Stent Market due to Higher Patency Rates

Growth in the value of the covered stent segment in the U.S. peripheral vascular stent market will outpace growth in the value of the bare-metal stent segment over the forecast period.

Read More